ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
1.150
-0.070 (-5.74%)
Dec 27, 2024, 4:00 PM EST - Market closed
ZyVersa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0.12 | 3.14 | 5.9 | 0.33 | 0.17 |
Cash & Short-Term Investments | 0.12 | 3.14 | 5.9 | 0.33 | 0.17 |
Cash Growth | -92.21% | -46.84% | 1696.27% | 88.12% | - |
Prepaid Expenses | 0.27 | 0.22 | 0.23 | 0.11 | 0.16 |
Other Current Assets | - | - | 0.24 | 0.38 | - |
Total Current Assets | 0.39 | 3.35 | 6.36 | 0.81 | 0.34 |
Property, Plant & Equipment | - | 0.01 | 0.12 | 0.03 | 0.04 |
Goodwill | - | - | 11.9 | - | - |
Other Intangible Assets | 18.65 | 18.65 | 100.09 | - | - |
Other Long-Term Assets | 0.18 | 0.1 | 0.05 | 0.29 | 0.31 |
Total Assets | 19.42 | 22.11 | 118.51 | 1.13 | 0.69 |
Accounts Payable | 9.28 | 8.43 | 6.03 | 2 | 2.31 |
Accrued Expenses | 2.25 | 1.25 | 0.8 | 0.75 | 1.16 |
Current Portion of Long-Term Debt | - | - | - | 9.15 | 2.13 |
Current Portion of Leases | - | 0.01 | 0.11 | - | - |
Current Income Taxes Payable | - | - | 0.11 | - | - |
Other Current Liabilities | 0.01 | 0.51 | 1.15 | 1.73 | 1.96 |
Total Current Liabilities | 11.54 | 10.19 | 8.19 | 13.63 | 7.56 |
Long-Term Debt | - | - | - | - | 1.69 |
Long-Term Deferred Tax Liabilities | 0.85 | 0.84 | 10.32 | - | - |
Other Long-Term Liabilities | - | - | 0.33 | 0.33 | 0.33 |
Total Liabilities | 12.4 | 11.04 | 18.84 | 13.96 | 9.57 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 118.25 | 114.3 | 104.58 | 40.07 | 35.92 |
Retained Earnings | -111.21 | -103.22 | -4.92 | -52.9 | -44.81 |
Treasury Stock | -0.01 | -0.01 | - | - | - |
Total Common Equity | 7.03 | 11.07 | 99.66 | -12.83 | -8.89 |
Shareholders' Equity | 7.03 | 11.07 | 99.66 | -12.83 | -8.89 |
Total Liabilities & Equity | 19.42 | 22.11 | 118.51 | 1.13 | 0.69 |
Total Debt | - | 0.01 | 0.11 | 9.15 | 3.82 |
Net Cash (Debt) | 0.12 | 3.13 | 5.79 | -8.82 | -3.64 |
Net Cash Growth | -92.04% | -45.99% | - | - | - |
Net Cash Per Share | 0.18 | 32.09 | 0.25 | -3.65 | -53.94 |
Filing Date Shares Outstanding | 2.34 | 0.83 | 0.12 | 24.17 | 0.07 |
Total Common Shares Outstanding | 1.07 | 0.41 | 0.03 | 24.17 | 0.07 |
Working Capital | -11.15 | -6.84 | -1.83 | -12.81 | -7.22 |
Book Value Per Share | 6.54 | 27.33 | 3868.91 | -0.53 | -131.63 |
Tangible Book Value | -11.62 | -7.57 | -12.32 | -12.83 | -8.89 |
Tangible Book Value Per Share | -10.82 | -18.69 | -478.20 | -0.53 | -131.63 |
Machinery | - | 0.05 | 0.05 | 0.05 | 0.05 |
Source: S&P Capital IQ. Standard template. Financial Sources.